Brief: Hamlet Pharma completes preclinical studies in two animal models

Hamlet BioPharma AB

21/07/2017 10:02

July 21 (Reuters) - HAMLET PHARMA AB  HAMLET.ST  
    * HAMLET PHARMA HAS SUCCESSFULLY CONDUCTED PRECLINICAL 
TOXICOLOGY/SAFETY STUDIES IN TWO DIFFERENT ANIMAL MODELS 
    * RESULTS SHOW THAT ALPHA1H IS WELL TOLERATED AND CAUSES NO 
LOCAL TOXICITY 
 
Source text for Eikon:  ID:nWkrmsqdj  
Further company coverage:  HAMLET.ST  
 
 (Gdynia Newsroom) 
 ((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))